Articles

Vietnam has been working for nearly a decade to develop and manufacture influenza vaccines. With PATH support, the Institute of Vaccines and Medical Biologicals has done just that—and it has submitted two candidates for licensure.

Improving vaccine coverage rates and vaccine acceptability in Serbia are critical issues. Locally made vaccines might be a part of the solution.

Serbia’s Institute of Virology, Vaccines, and Sera “Torlak” is a trusted, recognized vaccine producer in Serbia. As part of the influenza vaccine development project, it conducted its first complex vaccine clinical trial in humans, which helps position Torlak as an essential vaccine producer for the Balkan region.

What's it like to volunteer for for a clinical trial? One participant in Vietnam reflects on the opportunity to contribute to the country's influenza defenses.